- Scholarly Journal
LB2. Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

PDF
CiteCite
Copy URL
https://www.proquest.com/scholarly-journals/lb2-switch-doravirine-lamivudine-tenofovir/docview/3171059516/se-2?accountid=208611
PrintAll Options